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ABSTRACT
Mammalian de novo DNA methyltransferases (DNMT)
are responsible for the establishment of cell-type-
specific DNA methylation in healthy and diseased
tissues. Through genome-wide analysis of de novo
methylation activity in murine stem cells we uncover
that DNMT3A prefers to methylate CpGs followed
by cytosines or thymines, while DNMT3B predom-
inantly methylates CpGs followed by guanines or
adenines. These signatures are further observed at
non-CpG sites, resembling methylation context ob-
served in specialised cell types, including neurons
and oocytes. We further show that these prefer-
ences result from structural differences in the cat-
alytic domains of the two de novo DNMTs and are
not a consequence of differential recruitment to the
genome. Molecular dynamics simulations suggest
that, in case of human DNMT3A, the preference is due
to favourable polar interactions between the flexible
Arg836 side chain and the guanine that base-pairs
with the cytosine following the CpG. By exchanging
arginine to a lysine, the corresponding side chain
in DNMT3B, the sequence preference is reversed,
confirming the requirement for arginine at this posi-
tion. This context-dependent enzymatic activity pro-
vides additional insights into the complex regulation
of DNA methylation patterns.
INTRODUCTION
DNAmethylation plays important roles duringmammalian
development and the perturbation of this mark is often as-
sociated with human disease. In mammals, DNA methyla-
tion is deposited by the de novo DNA methyltransferases
DNMT3A and DNMT3B, while during replication, the
maintenance methyltransferase DNMT1 ensures correct
propagation of the methyl mark (1). Numerous genome-
wide studies identified the exact position and tissue-specific
dynamics of individual methyl groups on DNA. These re-
vealed that the majority of CpGs in mammalian genomes
are methylated, with the exception of active promoters
and cell-type-specific enhancer elements (2,3). In addition
to CpG methylation, non-CpG (or CpH) methylation has
been identified in numerous tissues (2,4,5), with highest lev-
els found in brain where it is suggested to contribute to gene
regulation and neuronal function through readout by the
methyl-CpG-binding protein MeCP2 (6–9).
Nevertheless, the mechanisms governing the precise de-
position of DNA methylation to the genome remain to be
fully understood. Although the mammalian genome is al-
most entirely methylated (2,3), several regions rely on active
recruitment of de novo DNA methylation activity, includ-
ing promoters, enhancers and CpG islands (10–12), repeti-
tive elements (13,14), and transcribed gene bodies (15,16).
These sites also show tissue-specific variability of DNA
methylation and display altered methylation patterns in
many diseases (3,8,17–20). These observations suggest that
pathways that recruit de novo methylation vary from cell
type to cell type and that the genome-wide methylation pat-
terns are a composite picture resulting from combined ac-
tivity of multiple DNMT-targeting mechanisms and mech-
anisms that actively or passively remove methylation (21).
In previous work, we and others have shown that the de novo
DNMTs associate with genomic regions that are marked by
distinct chromatin modifications, resulting in enhanced de-
position of methyl marks at these sites. For example, read-
out of H3K36me3 by DNMT3B targets DNA methyla-
tion to transcribed gene bodies (16,22), while DNMT3A
shows increased preference for Polycomb-target sites and
H3K36me2 (23–25).
Besides these differences in chromatin-dependent target-
ing of the de novoDNMTenzymes, biochemical studies sug-
gest thatDNMT3AandDNMT3Bdiffer in their preference
for CpGs based on flanking sequences. In in vitro methy-
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lation assays, DNMT3A has been found to show prefer-
ences towards CpGs flanked by pyrimidines (Y) at the +2
position, downstream of the methylated C, while studies
using episomal constructs in cells indicate that DNMT3B
shows higher methylation activity at sequences containing
purines (R) at the same position (26–31). However, the com-
plex interactions of DNMTs with chromatin and their site-
dependent recruitment, it remains unclear if CpG-flanking
preferences are observed genome-wide. Some indications
come from the analysis of CpH methylation in various tis-
sues. Non-CpG methylation is predominantly deposited by
the de novo DNMTs (4,32–35) and tissues that have a pre-
dominant activity of either DNMT3A or DNMT3B show
different CpH methylation flanking preferences. In tissues
with high DNMT3A activity, like neurons or oocytes, the
predominant CpH methylation motif occurs at CpApC,
while in ES cells CpH methylation is predominantly de-
posited by DNMT3B and occurs at CpApG sites (2,20,35–
37). Taken together, these results suggest that enzymatic ac-
tivities of the de novo DNMTs could be influenced by local
sequence context to shape the cell-type-specificmethylomes.
Here, we have systematically interrogated the se-
quence preference of the de novo DNA methyltransferases
DNMT3A and DNMT3B in vivo. By re-evaluating avail-
able whole genome bisulphite datasets from cells expressing
de novo DNMTs in Dnmt-triple-KO mouse embryonic
stem cells lacking DNA methylation, we measured how
sequence context influences deposition of methylation at
CpG and CpH sites, genome-wide. We identify similarities
and enzyme-specific preferences of methylation activity
at cytosines in different sequence contexts. We show that
DNMT3A prefers to methylate cytosines at TACGYC
sites while DNMT3B prefers to methylate TACGRC,
resembling results obtained in vitro or using episomal
constructs (26–31). The same downstream preference is
retained at non-CpG sites, with pronounced preferences
for TACACC and TACAGC, respectively. Through ana-
lyzing the genome-wide distribution of flanking sequence
preferences, and furthermore, by investigating methylation
in cells with altered targeting of DNMT3A or DNMT3B,
we show that these preferences are largely independent of
the genomic location or chromatin-mediated recruitment
of DNMTs. The analysis of the available crystal structures
and atomistic simulations of the DNMT3A catalytic
domain and a DNA duplex suggest a potential mechanism
underlying this specificity, which relies on a flexible arginine
side chain at position 836 in human DNMT3A (832 in
mouse). We confirm the requirement for this arginine
in mediating DNMT3A-specific preferences and show
that replacing this side chain to the lysine found at the
corresponding position in DNMT3B, reverts the flanking
sequence preference.
MATERIALS AND METHODS
Cell line generation and cultivation
Dnmt1,3a,3b-triple-KO cells were obtained from (38). Cells
were cultured on 0.2% gelatine-coated dishes in DMEM
(Invitrogen) supplemented with 15% fetal calf serum (Invit-
rogen), 1× non-essential amino acids (Invitrogen), 1 mM
L-glutamine, leukemia inhibitory factor, and 0.001% b-
mercaptoethanol. DNMT3A2- and DNMT3B-expressing
Dnmt-TKO cell lines were obtained by recombinase-
mediated cassette exchange (RMCE) as previously de-
scribed (16).
Whole-genome bisulphite library preparation and sequencing
Whole-genome bisulphite sequencing for TKO cells ex-
pressing DNMT3A and DNMT3B was performed as de-
scribed (16). In brief, 6 ug sonicated, genomic DNA were
pre-mixed with SssI-methylated phage T7 and unmethy-
lated phage Lambda DNA (both 10 ng, sonicated) and se-
quencing libraries were prepared using the NEB ULTRA
and ULTRAII kits following manufacturer’s instructions
for genomic DNA library construction and using methy-
lated adaptors (NEB E7535S). Adaptor-ligated DNA was
converted by sodium bisulphite using the Qiagen Epitect
bisulphite conversion kit. Converted libraries were enriched
by 10 cycles of PCR with the following reaction composi-
tion: 1 l Pfu TurboCx Hotstart DNA polymerase (Strata-
gene), 5 l PfuTurbo Cx reaction buffer, 25 M dNTPs, 1
l universal and 1 l index primer. PCR cycling parame-
ters were: 95◦C for 2 min, 98◦C for 30 s, then 10 cycles of
98◦C for 15 s, 65◦C for 30 s and 72◦C for 3 min, ending
with one 72◦C for 5 min step. The reaction products were
purified twice using Ampure-XT beads. Quality of the li-
braries and size distribution were assessed on an Agilent
High Sensitivity tape station. Libraries were sequenced on
Illumina HiSeq and NovaSeq machines. All newly gener-
ated datasets (Supplementary Table S1) have been deposited
toGene ExpressionOmnibus (GEO), under accession num-
ber: GSE151992.
Whole-genome bisulphite data processing
Published WGBS datasets obtained from GSE57411,
GSE96529 and newly-generatedWGBS data including mu-
tant DNMT3A proteins and additional independent bio-
logical replicates (Supplementary Table S1) were individu-
ally pre-processed and aligned to the mouse genome. The
reason for including additional replicates (new cell lines,
WGBS libraries generated by different persons and se-
quenced on different machines) was to exclude that the ob-
served sequence preferences could stem fromunexpected bi-
ases in library preparation or sequencing technology. For
bulk analysis of CpGpN sites, the sequencing samples were
processed and aligned as described in (16). In brief, reads
were first trimmed to 50nt using fastx trimmer and then
aligned to the mouse genome (mm9) using BOWTIE in
QuasR qAlign() with standard options and bisulfite =
‘undir’ setting (39). Methylation calls for CpGs were ob-
tained using the qMeth() function in QuasR in ‘CpGcomb’
mode and excluding CpGs overlapping with known SNPs.
Bisulphite conversion efficiency was measured by spiked-in
controls of methylated T7 DNA and unmethylated lambda
DNA.
For detailed WGBS analysis using 8-mer motifs, the
full-length sequencing reads were pre-processed and
trimmed using cutadapt v1.16 (40) and sickle v1.33 (Joshi
and Fass 2011, https://github.com/najoshi/sickle) to re-
move adapter sequences. Read quality was measured
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before and after processing using FastQC v0.11.5 (https:
//www.bioinformatics.babraham.ac.uk/projects/fastqc/).
Processed reads were mapped against the mm9
mouse assembly using bwa-meth v0.2.0 (41) run-
ning bwa v0.7.12-r1039 (42). Mapping quality was
evaluated with qualimap v2.2.1 (43). Duplicates
were removed with Picard MarkDuplicates (picard-
tools v1.96, http://broadinstitute.github.io/picard/)
with ‘REMOVE DUPLICATES=TRUE and RE-
MOVE SEQUENCING DUPLICATES=TRUE’ flags.
Alignments with MAPQ > 40 were used as input to
methylation calling with methyldackel v0.3.0-3-g084d926
(https://github.com/dpryan79/MethylDackel) (using HT-
Slib v1.2.1) in ‘cytosine report’ mode for all cytosines in
the genome both CpG and CpH contexts (‘extract -q 40
–cytosine report –CHH –CHG’).
Sequence-dependent DNA methylation analysis
For global analysis of methylation preferences at CpGpN
sites, we first calculated the methylation scores for indi-
vidual CpG instances with min coverage = 10 and max
coverage = 50 in the WGBS datasets. Methylation scores
were obtained as: number of methylated reads/(number
of methylated +unmethylated reads) per CpG. We ob-
tained the CpGpN sequence context by extending the
CpGs by one nucleotide downstream on the + strand and
querying the mm9 sequence using the Biostrings package
in R (https://bioconductor.org/packages/release/bioc/html/
Biostrings.html). Average methylation scores were calcu-
lated for all CpGs falling in one of the four contexts:
CpGpA, CpGpT, CpGpG or CpGpC. The same analysis
was performed using only CpGpNs that were only cov-
ered in both datasets according to the criteria described
above (TKO-DNMT3A2 r1 and TKO-DNMT3B1 r1) and
CpGpN sites that are at least 80% methylated in wild
type ES cells. To evaluate the genome-wide distribution of
CpGpN methylation according to H3K36me3, the mouse
genome was partitioned into 1kb, nonoverlapping inter-
vals using GenomicRanges in R (44). Intervals overlapping
with satellite repeats (Repeatmasker), ENCODE black-
listed and low mappability scores (<0.5) were removed in
order to reduce artefacts due to annotation errors and
repetitiveness. First, we calculated the signal strength of
H3K36me3 at each individual interval by counting the
numbers of reads from available ChIP-seq experiments (45).
All genomic intervals were first ranked based on the total
number of H3K36me3 ChIP-seq reads. Then, the ranked
intervals were binned into groups of 1000 intervals, result-
ing in a total of 730 bins. Within each bin, we calculated the
average methylation falling into the four possible CpGpN
sequence contexts for each WGBS sample.
For the 8-mer specific analysis, first a dictionary contain-
ing a complete set of 8-mer motifs for NNNCGNNN and
NNNCHNNN was created. Next, we separately counted
all methylated or unmethylated individual WGBS reads
aligning in the corresponding orientation to every ge-
nomic instance containing the 8-mer of interest and cal-
culated the methylation score. The low-expression of the
re-introduced DNMT3 enzymes to TKO cells and the ab-
sence of DNMT1-mediated maintenance resulted in sparse
methylation, with the majority of CpG sites lacking DNA
methylation (Supplemental Figure S2B). To account for
the sparse methylation, we defined the methylation sta-
tus of each strand-specific 8-mer as methylated when at
least one methylated read was present. These genomic in-
stances of methylated and unmethylated 8-mers were then
collapsed into a list containing total methylated and un-
methylated instances per motif. This was done for each
WGBS dataset individually, resulting in a data frame sum-
marising methylated (M) and unmethylated (U) reads per
motif.Methylation scores per motif were obtained by calcu-
lating M/(M+U) and were used for generating motif ranks.
Position weight matrices were calculated and displayed us-
ing the seqLogo package in R.Nucleotide coupling analysis
upstream and downstream of the methylated target site was
calculated by first counting all methylated and unmetylated
instances containing NNCX or CXNN 4-mers, where X =
is either G or H depending on CpG of CpH context. Fi-
nally, the methylation score at all possible combinations at
–2/–1 or +2/+3 sites was calculated as described above and
represented as heatmaps.
To investigate the sequence preferences at genomic sites
preferentially bound by DNMT3A or DNMT3B, we made
use of genomic regions we previously defined as enriched
for these two enzymes (23). Next, we used these regions to
separately calculate the methylation at CpGpN sites as well
as for all possible 8-mer motifs in presence of DNMT3A or
DNMT3B.
Molecular dynamics system preparation
The crystal structure of human DNMT3A-DNMT3L in
complex with double-stranded DNA containing two CpG
sites (PDB ID: 5YX2) (46) was used as the structural basis
of this study. We reduced the complex to one DNMT3A
methyltransferase interacting with a 10-mer DNA, con-
taining one CpG site, and an S-adenosyl-L-homocysteine
(SAH) cofactor (Supplementary Figure S10B). For the sim-
ulations, the zebularine in the crystal structure was re-
placed by a cytosine methylated at C5. Furthermore, four
nucleotides in the DNA sequence present in the crystal
structure (two nucleotides preceding and two following the
methylation site) were mutated to accommodate the ob-
served preferences of DNMT3A and DNMT3B (Supple-
mentary Figure S10A). The mutation of the nucleotides
and the reconstruction of the missing residues in the
crystal structure were performed using the Maestro soft-
ware (Schrödinger, release 2020-1). The methyltransferase
DNMT3A, the rest of the DNA chain, the cofactor and the
crystal water molecules were kept as in the crystal structure.
Molecular dynamics simulations
Overall, 34 000 node hours using 72 virtual cores per node,
were used to carry out the simulations on Piz Daint at
the Swiss National supercomputing Centre. All simulations
were carried out using the GROMACS 2018.6 simulation
package (47) and the CHARMM36m force field (48). Five
independent 1-s simulations with different initial random
velocities were carried out for each system. To reproduce
neutral pH conditions, the Arg and Lys side chains an N-
terminus were positively charged, while the Asp and Glu
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side chains and the C-terminus were negatively charged.
Furthermore, the 5′- and 3′-termini in the DNA sequence
were cappedwith phosphate groups andOHgroups, respec-
tively. Each system was solvated in a cubic box (edge length
of 13.9 nm) with TIP3P water molecules (49) to which
150 mM NaCl were added, including neutralizing counte-
rions. Periodic boundary conditions were applied. Follow-
ing steepest descent minimization, the systems were equili-
brated under constant pressure for 2 ns, with position re-
straints applied on the heavy atoms of the complexes. Tem-
perature and pressure were maintained constant at 300 K
and 1 atm, respectively, by using the modified Berendsen
thermostat (0.1 ps coupling) (50) and barostat (2 ps cou-
pling) (51). For the production runs, performed in the NVT
ensemble, harmonic restraints (force constant K = 1000
kJ/(mol·nm2)) were used for the heavy atoms of the end nu-
cleotides and snapshots were saved every 50 ps. The short-
range interactions were cut-off beyond a distance of 1.2 nm
and the potential smoothly decays to zero using the Verlet
cutoff scheme. The Particle Mesh Ewald (PME) technique
(52) with a cubic interpolation order, a real space cut-off of
1.2 nm and a grid spacing of 0.16 nmwas employed to com-
pute the long-range interactions. Bond lengths were con-
strained using a fourth order LINCS algorithm with two
iterations (53). In all simulations the time step was fixed to
2 fs.
RESULTS
De novo DNA methyltransferases display flanking sequence
preferences in murine stem cells
To examine DNA sequence specificities of de novo methyl-
transferases in vivo, we first made use of available whole-
genome bisulphite sequencing (WGBS) from Dnmt-triple-
KO (TKO) mouse embryonic stem cells where the de novo
DNA methyltransferases DNMT3A2 or DNMT3B1 were
reintroduced to the genome (16) (Supplementary Table S1).
In these cells, replication-coupled maintenance of de novo
methylated DNA is lacking in absence of DNMT1 and the
WGBS data directly allows us to identify de novo DNA
methylation activity by DNMT3A or DNMT3B. We lever-
aged this to investigate if the favoured and disfavoured
DNA sequence contexts reported in vitro, are indeed also
observed in cells. First, we calculated the average DNA
methylation in the TKO-DNMT3A2 and TKO-DNMT3B1
samples at CpGs in all four CpGpN contexts. Although
each CpGpN sequence context was equally represented
in the TKO-DNMT3A2 and TKO-DNMT3B1 WGBS li-
braries (Supplementary Figure S1A-C), DNA methyla-
tion analysis indicated a sequence-preference which dif-
fered between DNMT3A and DNMT3B (Figure 1A). The
DNMT3A sample showed increased methylation at cy-
tosines in a CpGpT and CpGpC sequence-context, indi-
cating a preference towards pyrimidines at the +2 posi-
tion from the methylated cytosine (CGY), and DNMT3B
at cytosines in a CpGpA and CpGpG context, containing
purines at the +2 position (CGR). To further test if the ob-
served difference could be influenced by the genomic con-
text or different library representation of the queried se-
quences, we re-calculated the methylation scores only on
the same CpGpNs that were covered in both, the TKO-
DNMT3A2 and the TKO-DNMT3B1 libraries (Supple-
mentary Figure S1D), and also on CpGpNs that were at
least 80% methylated in wild type ES cells (Supplementary
Figure S1E). The latter was necessary to exclude that ac-
tive promoters and enhancers with elevated levels of DNA
methylation turnover due to active DNA de-methylation
(2,3,21) could have a potential influence on the calculated
methylation scores. In both cases, the same sequence prefer-
ence was observed when using these refined CpG sites (Sup-
plementary Figure S1D and E). Finally, we generated new,
independent Dnmt-TKO cell lines expressing DNMT3A2
and DNMT3B1 and repeated the WGBS analysis centred
around CpGpN sites, resulting in identical sequence pref-
erences and excluding potential artefacts stemming from
library preparation, bisulphite conversion or sequencing
technology (Supplementary Figure S1F and Table S1).
Following these results, we wanted to have a more de-
tailed view on the sequence preferences of DNMT3A and
DNMT3B. Towards this, we expanded our analysis to 8-
mer strings with a fixed CpG in the centre (NNNCGNNN)
and calculated the methylation scores on the forward or re-
verse strands separately. We first ranked the obtained se-
quences according to the average methylation score calcu-
lated from all 8-mer instances in the Dnmt-TKO cells ex-
pressing DNMT3A2 or DNMT3B1 (Supplementary Fig-
ure S2A-B). This ranking allowed us to identify DNA se-
quences that were preferentially methylated by DNMT3A
and DNMT3B. Top-ranking 8-mers indicated similarities
and individual preferences in nucleotides at the queried po-
sitions (Figure 1B). For example, we observed that both
enzymes have a slight preference for adenines (A) at the
-1 position and cytosines (C) at the +3 position. We ob-
served an increased occurrence of thymines (T) at the –2
position at DNMT3B-preferred sites, which was even more
prominent atDNMT3A targets (Figure 1B). On top of that,
we again observed the +2-nucleotide preference for pyrim-
idines at DNMT3A targets, where Cs and Ts were equally
represented, while DNMT3B displayed an increased prefer-
ence for purines, especially guanines (G) (Figure 1B). These
position-specific preferences flanking CpGs can be further
observed when calculating the methylation difference be-
tween DNMT3A and DNMT3B for each individual nu-
cleotide position in the 8-mer (Supplementary Figure S2C).
By grouping the ranked 8-mers into 20 bins we could
furthermore calculate the sequence preferences within each
bin and display the results as DNA sequence logos (Figure
1C and Supplementary Figure S3A and B). Importantly
we only observed sequence preferences at the top-ranked
and bottom-ranked 8-mers, but not at 8-mers ranked in the
centre (Supplementary Figure S3A andB). The least methy-
lated 8-mers allowed us to identify sequences that were
disfavoured by the enzymes. These predominantly con-
tained purines (G/A) at the –2 position for both enzymes,
but we also observed differences at the –1 and +2 position,
where DNMT3B showed reduced methylation preference
near pyrimidines located at –1 and +2, while DNMT3A did
not indicate strong occurrence of disfavoured nucleotides
(Supplementary Figure S3A-B). These results are in line
with previous reports obtained from incubating DNMT3A
or DNMT3B with DNA substrates (29–31), indicating
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Figure 1. De novo DNMTs display flanking sequence preferences at CpG and non-CpG sites. (A) Bar plots indicating average methylation scores at CpG
sites followed by A, T, C and Gs (CpGpN). Average methylation for CpGpNs falling into one of the four categories was calculated from WGBS data
obtained from Dnmt-TKO ES cells expressing either DNMT3A2 or DNMT3B1. (B) Nucleotide composition at top 5% from 8-mers ranked by CpG
methylation in DNMT3A2 or DNMT3B1-expressing TKO cells. Pie charts show the distribution at the individual positions according to the methylated
cytosine: C. Top 10 methylated sequences are shown. (C) Position weight matrix calculated from the top 5% 8-mers methylated by either DNMT3A2 or
DNMT3B1 indicate the preferred DNA sequence motif. (D) Position weight matrix calculated from the top 5% 8-mers methylated by either DNMT3A2
or DNMT3B1 indicate the preferred DNA sequence motif at non-CpG sites. (E) Heatmap showing the effect of dinucleotide coupling at positions –2/–1
or +2/+3 on CpG methylation (at position 0/+1).
that the flanking preferences observed in vitro are prevalent
in cells and even in presence of chromatin. Analysis of
sequencing coverage distribution for all 8-mers again
results in identical coverages between TKO-DNMT3A2
and TKO-DNMT3B1 (R = 0.995, Supplementary Fig-
ure S4A and B). In addition, the calculated 8-mer
sequence preferences were identical between replicates of
DNMT3A2 and DNMT3B1, confirming the observed
preferences in independent replicates (Supplementary
Figure S4C).
Finally, we extended this analysis to all sequences
containing a CpH site in the centre of the 8-mer
(NNNCHNNN). Ranking all sequences by their average
methylation score results in a high preference for CpA
methylation for both enzymes (Figure 1D and Supplemen-
tary Figure S5A), in accordance with previous results ob-
tained from in vitro assays (54) or analysis of non-CpG
methylation in mammalian genomes (55). Both enzymes
show a preference for T and A at position –2 and –1, re-
spectively (Figure 1D and Supplementary Figure S5A). In
addition, we observe again a DNMT3A-specific methyla-
tion preference for CpA sequences frequently followed by a
C at position +3 (CpApC), whileDNMT3Bprefers CpApG
sites, with position +3 being less defined (Figure 1D and
Supplementary Figure S5A-B). Importantly, the observed
motifs resemble the reported non-CpG motifs observed
in ES cells or neuronal tissues (2,5,20,55), indicating that
these indeed stem from the activity of the individual de
novomethyltransferases operating in these cell types. We re-
peated the ranking independently for sites containing CpA,
CpT and CpC dinucleotides, resulting in similar DNMT3-
specific sequence preferences for position +2 at CpA and
CpT sites, while methylation at CpC-containing sequences
was similar between both enzymes, likely due to low methy-
lation scores in this context (Supplementary Figure S5C
and D).
Individual and combinatorial influence of flanking nucleotides
on DNMT3A and DNMT3B activity
Ranking of 8-mers suggested that the sequence context sur-
rounding the CpG/CpH sites has a strong influence on
the methylation activity. Next, we wondered if coupling
of neighbouring nucleotides could have an influence on
DNMT3A or DNMT3B activities and we calculated the
methylation scores resulting for all possible combinations
at the dinucleotides positioned immediately upstream and
downstream of the CpGs (Figure 1E). This analysis indi-
cates that for preceding positions (–2 and –1) DNMT3A
and DNMT3B mainly prefer to methylate downstream of
TpA dinucleotides (Figure 1E). Similar dinucleotide com-
position preferences can be observed upstream of CpH
methylated sites (Supplemental Figure S6A). Analysis of
downstream preferences indicates that DNMT3A methy-
lation is preferentially targeted to CpGs followed by CpC
or TpC > CpT or TpA > CpA (Figure 1E). In case of
DNMT3B, methylation is preferentially targeted to CpG
dinucleotides followed by GpC >> ApG at positions
+2 and +3 (Figure 1E). These downstream di-nucleotide
preferences are partially resembled at CpH sites, where
DNMT3A prefers to methylate primarily non-CpGs up-
stream of CpC dinucleotides and DNMT3B sites followed
by GpC > GpG or GpT (Supplemental Figure S6A). The
results at CpH sites suggest a more defined flanking se-
quence preference at position +2, where only cytosines and











































































Figure 2. Flanking sequence preferences scale with, but are independent of the genomic location of the DNMTs. (A) Preferential de novo methylation of
purines by DNMT3B is not altered by its general preference for H3K36 tri-methylated sites. Shown are de novo DNA methylation at all four CpGpN
context genome-wide in relation to H3K36me3 enrichment. 1-kb-sized genomic intervals were ranked and grouped by H3K36me3 enrichment (1000
intervals per bin) and DNA methylation was calculated per bin. Lines indicate mean DNA methylation per bin in TKO cells expressing DNMT3B1 (left)
or DNMT3A2 (right). (B) Heatmap indicating strong correlation in DNA sequence preference between the DNMT3A1 and DNMT3A2 isoforms, or
between DNMT3B1 in presence and absence of H3K36me3. Correlations between identical samples were removed and are shown in gray.
guanines appear to be enzymatic signatures of DNMT3A
and DNMT3B, respectively.
Differential localisation of de novoDNMTs influences the ge-
nomic distribution of methylated motifs
The DNMT3 proteins display distinct genome-wide local-
isation patterns correlating with the genomic distribution
of histone modifications. In case of DNMT3B, methyla-
tion is preferentially targeted toH3K36me3 (16). To investi-
gate how the observed sequence preference follows this ge-
nomic localisation pattern, we first analysed the genome-
wide distribution of CpGpN methylation according to
H3K36me3 in DNMT3A2 or DNMT3B1-reconstituted
Dnmt-TKO cells. We ranked 1 kb genomic intervals accord-
ing to H3K36me3 levels and calculated the mean methyla-
tion score for each CpGpNmotif at each interval. In case of
DNMT3B, we see a clear dependence onH3K36me3, where
the total CpG methylation (independent of the nucleotide
at +2 position) increases with H3K36me3, as previously
reported (16) (Figure 2A). When comparing the methyla-
tion at individual CpGpN sites, we observe that although
methylation at CpGpG and CpGpA sites clearly increases
withH3K36me3 levels, themethylation ratio ofG/Aover C
and T at the +2 position remains constant – independent of
H3K36me3 and total methylation (Figure 2A). The methy-
lation introduced in the DNMT3A2 reconstitution exper-
iments shows similar constant distributions of methylated
CpGpN motifs, but with reversed preferences for A/T over
G/A at the +2 position (Figure 2A). The same result is ob-
served when we investigate re-methylation at genomic re-
gions preferentially bound by DNMT3A or DNMT3B in
mouse ES cells (23). While the overall levels of CpGmethy-
lation at these sites are in agreement with the binding pref-
erence of the re-introduced DNMT3 enzyme in the Dnmt-
TKO cells, the enzyme-specific sequence preferences for +2
nucleotides remain intact, independent of the binding site
(Supplementary Figure S7A–C).
In general, this indicates that genomic localisation pri-
marily determines local enzymatic activity, while differ-
ences in enzymatic flanking preference by DNMT3A or
DNMT3B can result in preferred methylation of cytosines
followed by pyrimidines or purines at the +2 position, re-
spectively. This is also evident from analysing the distribu-
tion of non-CpG methylation in wild type ES cells express-
ing all DNMT enzymes (3), where CpApG shows slightly
higher methylation at sites bound by DNMT3B (Supple-
mentary Figure S7D-E). However, potential redundancies
in presence of DNMT3A and DNMT3B isoforms as well
as heterodimers between these enzymes (56,57) could result
in less clear flanking preferences. To investigate how absence
of either DNMT3A or DNMT3B in fully-methylated cells
influences the observed flanking sequence preferences, we
made use of available WGBS datasets obtained in human
ES cells (hESC), hESC-derived endodermal cells (CD184)
and hESC-derivedmotor neurons lacking either DNMT3A
or DNMT3B (35,58). We observe a stronger global reduc-
tion in methylation at CpG sites followed by pyrimidines in
cells lackingDNMT3A, while cells lackingDNMT3B show
a stronger reduction at CpG sites followed by purines (Sup-
plementary Figure S7F).
Preference to methylate at different flanking sequences is de-
termined by the catalytic domain
Recruitment of de novoDNMTs to the genome is predomi-
nantly regulated through the non-catalytic N-terminal part
and its interactions with chromatin. To directly test how
chromatin-dependent recruitment may influence the flank-
ing sequence preference, we first re-evaluated additional
WGBS datasets where we deleted SETD2, the enzyme re-
sponsible for deposition of H3K36me3 (59), in Dnmt-TKO
cells expressing DNMT3B (here termed quadruple-KO,
QKO). We and others have previously shown by ChIP-
seq, that in absence of SETD2, binding and methylation
activity of DNMT3B to actively transcribed gene bodies
is lost (16,22). This is also observed when we reanalyse
the DNA methylation in the context of CpGpN, where
all four sequence contexts are equally affected but retain
the preference of purines over pyrimidines (Supplemen-
tary Figure S8A). By further comparing the methylation
scores at 8-mers obtained from DNMT3B-QKO cells with
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cells containing H3K36me3, we observe the same flank-
ing preference for CpG and non-CpG sites, despite the
lack of de novo methylation targeting to H3K36me3 sites
(Figure 2B and Supplementary Figure S8B–D). In addi-
tion, we have investigated if the previously-reported differ-
ential genomic localization of DNMT3A isoforms 1 and 2
(23,24) would influence flanking sequence preferences. By
comparing the results obtained in TKO-DNMT3A2 with
a WGBS dataset obtained from Dnmt-TKO cells express-
ing the longer DNMT3A1 isoform, we could not observe
any differences in methylated sequence contexts (Figure 2B
and Supplementary Figure S8E-G). This also holds true
when we compare the datasets at genomic regions with dif-
ferential de novo DNMT binding (Supplementary Figure
S8H), excluding that recruitment of DNMTs based on his-
tone modifications is responsible for the observed sequence
preference at +2 position. This suggests differences in the
catalytic domain of DNMT3A and DNMT3B, rather than
genomic localisation, as the source of the observed differ-
ence in flanking sequence preference (Supplementary Fig-
ure S8I).
Direct comparison between DNMT3A and DNMT3B cat-
alytic domains reveals structural constraints on methylation
preference
The observed sequence preferences could stem from struc-
tural differences in the catalytic domains of DNMT3A
and DNMT3B. Towards this we first focused our atten-
tion on divergent amino acids in the catalytic domains of
DNMT3A and DNMT3B. Of the 279 residues in the cat-
alytic domain, 44 vary between DNMT3A and DNMT3B
(Supplementary Figure S9A). We made use of available
crystal structures of human DNMT3A in complex with
DNA (46) (PDB ID:6F57) and used DNAproDB (60) with
standard interaction criteria to identify which of the variant
amino acids interact with the DNA upstream and down-
stream of themethylated CpG (Figure 3A).We observe that
only two variant amino acids are in close contact with the
nucleotide bases around the methylated CpG (Figure 3A
and Supplementary Figure S9A). The catalytic loop residue
I715 (N656 in human DNMT3B) sits in the minor groove
of the DNA and contacts the G at –1 position on the same
strand, and the A at the−2′ position on the opposite strand
of the modified CpG (Figure 3A, B and Supplementary
Figure S9B). The corresponding N656 in DNMT3B crys-
tal structures in complex with DNA (61) shows a similar
interaction with the minor groove and contacts the A at the
−2′ position on the opposite strand (Figure 3A, B and Sup-
plementary Figure S9C). The interactions of I715 andN656
with the adenine at position −2′ could contribute to the el-
evated preference for Ts at position –2 on the methylated
strand, which is observed for both enzymes (Figure 1C).
The variant residue R836 in the target recognition
domain (TRD) of human DNMT3A (K777 in human
DNMT3B) contacts the +1 to +3 nucleotide pairs in the
major groove downstream of the methylated CpG (Fig-
ure 3A). This residue was previously suggested to be in-
volved in mediating the preference for G at the +1 posi-
tion in the CpG site (46). In DNMT3B, it is rather N779
(N838 in DNMT3A) that mediates the specificity for the
G nucleotide at position +1 of the methylated CpG, while
K777 (corresponding to R836 in DNMT3A) contributes
towards the DNMT3B-specific flanking preference for Gs
at position +2 (30,61). Interestingly, a recent crystal struc-
ture of human DNMT3A together with a DNA molecule
containing CpGpA shows that the R836 side chain flips
away from the G at +1 to interact with the flanking nu-
cleotides downstream of the CpG indicating increased flex-
ibility in the TRD loop (62). Given these observations, we
wanted to investigate how the potential flexibility of the
R836 side chain contributes to the observed flanking prefer-
ence of DNMT3A at position +2. Superimposition of avail-
able structures of DNMT3A and DNMT3B in complex
with DNA (46,61) indicate that both residues (DNMT3A
R836 and DNMT3B K777) can contact the nucleotides at
position +2, but the side chains are oriented in opposite di-
rections (Figure 3C). In the respective crystal structures, the
DNMT3BK777 side chain contacts the guanine at position
+2 on themethylated strand, while theDNMT3AR836 side
chain contacts the guanine at position +2′ on the opposite
strand (Figure 3C and Supplementary Figure S9D-E). The
opposing orientations and interactions on opposite strands
could point to a potential mechanism underlying the ob-
served DNMT-specific preference at position +2.
Atomistic simulations reveal interaction dynamics between
DNMT3A R836 and DNA
To investigate the structural plasticity of the DNMT3A-
DNA interactions we performed molecular dynamics
(MD) simulations starting from a DNMT3A/decameric
DNA complex extracted from the crystal structure of hu-
man DNMT3A-DNMT3L-DNA (PDB ID: 5YX2) (46).
Two simulation systems were prepared differing only at
the position +2 of the 10-mer DNA duplex, namely
CATAmCGCCCT and CATAmCGGCCT (boldface for
position +2, Supplementary Figure S10A). The nucleotides
preceding the methylation site were mutated to T and A
to accommodate the observed preferences of DNMT3A
and DNMT3B. Both systems contained also a molecule of
the co-productS-adenosyl-L-homocysteine (SAH) (Supple-
mentary Figure S10B). Five independent simulations were
carried out for each system for a total sampling of 5s (Ma-
terials and Methods). We focused the analysis on the inter-
action between R836 and the DNA duplex and in partic-
ular the closest nucleotide, that is G or C at position +2′
on the unmethylated strand (Figure 3C) and calculated the
shortest distance between any pairs of non-hydrogen atoms
along the MD trajectories. In presence of the disfavoured
sequence, the histogram of the distance between R836 and
the cytosine at position +2′ shows a maximum at about
4 Å which corresponds to van der Waals contacts (Figure
4A and Supplementary Movie 1). Interestingly however, in
the presence of the favoured sequence the distance between
R836 and the guanine at position +2′ shows a bimodal dis-
tribution with a peak at hydrogen bond distance (∼2.7 Å)
and a broad region up to 5.5 Å (Figure 4A). This indicates
a potential switch in the orientation of the R836 side chain,
resulting in two conformational states which we here call
‘R836-in’ and ‘R836-out’. Indeed, the simulations reveal
that in presence of the preferred sequence the guanidinium












































































Figure 3. Structural differences between human DNMT3A and DNMT3B provide potential cues for observed sequence preferences. (A) Schematic
overview of DNAproDB-reported intermolecular interactions between human DNMT3A and DNA, based on PDB ID: 6F57. Edges represent inter-
actions between DNMT3A amino acid residues and DNA, while colours represent interactions with the major groove in blue, minor groove in pink and
bases in grey. Position of interacting amino acids within DNMT3A protein secondary structures are shown as red circles for alpha helices, green triangles
for beta strands and blue squares for loops. (B) Residues I715 of human DNMT3A (PDB ID: 6F57) and N656 of human DNMT3B (PDB ID: 6KDA)
interact with the minor groove of the DNA by contacting the A at the –2 position on the opposite strand of the modified CpG. (C) Residues R836 of
DNMT3A and K777 of DNMT3B interact with the DNA downstream of the methylated CpG through interactions with the major groove at position
+2. The side chains show opposing orientation, with K777 (PDB ID 6KDA) contacting the guanine on the methylated strand and R836 (PDB ID: 6F57)
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Figure 4. Molecular dynamics simulations reveal potential mechanisms underlying DNMT3A preference for CpGpC sites. (A) Histograms displaying the
measured distance between the R836 side chain and the base at position +2′ for the disfavored (top) and the favored (bottom) DNA duplex sequence. For
the favored sequence, a broad region and a peak are observed corresponding to the state before the conformational switch (‘R836-out’ state) and after
(‘R836-in’ state). (B,C) The two interactions states ofDNMT3AR836 and the preferredDNA sequence obtained from theMD simulations.Magnifications
show the distances between DNMT3A R836 and the guanine at position +2′ for the ‘R836-out’ (in B) and ‘R836-in’ state (in C). The hydrogen bonds
between the nitrogen atoms of the guanidinium group of R836 and the carbonyl oxygen and N7 nitrogen of the guanine at position +2′ are indicated.
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group of R836 can form two hydrogen bonds, respectively,
with the carbonyl oxygen and N7 nitrogen of the guanine
at position +2′ (i.e. the guanine that base-pairs with C at
+2) resulting in the ‘R836-in’ state (Figure 4B, C, Movies
2–3, and Supplementary Figure S10D-F). This switching of
R836 is in line with the crystal structure of DNMT3A in
complex with DNA containing the disfavoured CpGpA se-
quence, suggesting that this side chain dynamically interacts
with DNA, depending on the flanking nucleotides down-
stream of CpG (62). In our simulations, the total interaction
energy between the side chain of R836 and its surrounding
(DNA, protein, and solvent) is similar for the disfavoured
DNA sequence and the two states of the favoured DNA se-
quence (Supplementary Figure S10C). Concerning the indi-
vidual contributions, the interaction energy between R836
and DNA is about 15 kcal/mol more favourable for the
‘R836-in’ state than the ‘R836-out’, and the latter is simi-
lar as in the disfavoured sequence (Supplementary Figure
S10C). The difference in interaction energy originates al-
most only from the aforementioned hydrogen bonds. The
additional hydrogen bonds with DNA (more precisely with
the G at position +2′ in the favoured DNA sequence) are
compensated by a loss of interactions between R836 and
the solvent (Supplementary Figure S10C). Thus, the MD
simulations indicate that the direct interactions between
R836 and methylated DNA duplexes containing CpGpC
sites are more favourable compared to CpGpG sites, while
the interaction energy of R836 and the rest of the system
(protein/DNA complex and solvent) is similar.
An arginine to lysine substitution reverts the DNMT3A se-
quence preference at position +2
To directly test the contribution of this arginine side chain
towards the observed DNMT3A flanking-sequence prefer-
ence, we generated two independent Dnmt-TKO cell lines
expressingmutantmouseDNMT3A2proteins wherewe ex-
changed the arginine at position 613 (= position 836 in full
length human DNMT3A) to a lysine––the corresponding
side chain present in DNMT3B.We named these mutations
R836K to retain consistency with the structural analysis
based on humanDNMT3A. In addition, we have generated
two independent Dnmt-TKO cell lines expressing mouse
DNMT3A2 bearing an I to N substitution at position 492,
corresponding to the second variant amino acid in human
DNMT3A I714, that presumably contacts the –2 and –1
nucleotides in the crystal structures (I714N, Figure 3A, B).
WGBS analysis shows that, while the I715N replacement
does not influence the sequence preference downstream of
the CpG site, the R836 replacement reverses the preference
of DNMT3A to partially resemble that of DNMT3B with
decreased methylation at CpGs followed by Cs and Ts (Fig-
ure 5A, B and Supplementary Figure S11A, B). This change
in sequence preference is also evident when we cluster the
samples based on the methylation scores at 8-mer mo-
tifs, where DNMT3A2-R836K clusters closer to DNMT3B
(Figure 5C and Supplementary Figure S11C). The cluster-
ing analysis based on the 8-mer motifs further indicates
a slight change in sequence preference for the DNMT3A-
I715Nmutant. Direct comparison of nucleotide preferences
between mutant and wild type DNMT3A at individual po-
sitions reveals a minor shift at positions –2 and –1 in the
I715N mutant, where less-frequent adenines at –2 are re-
placed by guanines and thymines are slightly increased at
–1 (Supplementary Figure S11D). However, this does not
resemble the preference observed for DNMT3B, suggest-
ing that this side chain is not relevant for the observed nu-
cleotides at –2 and –1 (Figure 5B and Supplementary Fig-
ure S11E). In contrast, the R836K replacement results in a
change in preference from pyrimidines to purines at posi-
tion +2, resembling sequences observed in DNMT3B (Sup-
plementary Figure S11E, F). Similar changes in flanking
sequence preference are observed at non-CpG sequences,
where R836K leads to increased preference for purines at
position +2 (Supplementary Figure S12A, B), without af-
fecting global ratios in methylation at CpG and non-CpG
sites (Supplementary Figure S12C).
DISCUSSION
Sequence-specific flanking preferences have been first de-
scribed for the de novo DNA methyltransferases based on
in vitro methylation experiments or using episomal con-
structs in cells (26–28,63). In addition, analysis of tissue-
specificWGBS data indicates that sequence-context of non-
CpG methylation strongly varies between tissues express-
ing DNMT3A or DNMT3B (2,20,35–37). Together, these
reports suggest that DNA sequence preferences of the de
novo DNMTs could provide an additional layer of methy-
lome regulation. However, it remained to be clarified if
these enzyme-specific preferences occur in vivo and genome-
wide. Especially, given the reported differential localisation
and cell-type-specific activities of de novo DNMTs, it re-
mained a challenge to directly and comprehensively com-
pare the enzymatic preferences of these enzymes in the same
genomic environment. By evaluating a set of previously-
published and newly-generated whole-genome bisulphite
sequencing data obtained from Dnmt-TKO ES cells lack-
ing DNA methylation with re-introduced individual de
novo enzymes, we were able to characterize the genomic
flanking preferences of DNMT3A and DNMT3B at un-
precedented detail. Here, we show that DNMT3A prefers
to methylate predominantly in a NTACGYCN context,
while DNMT3B prefers NTACGRCN.We find nucleotides
around the methylated site that are equally preferred by
both enzymes and furthermore, highlight that the +2 nu-
cleotide following the methylated cytosine is the strongest
determinant of enzyme-specific sequence preference, con-
firming very recently published results using large scale
in vitro measurements and WGBS datasets (30,31). The
flanking sequence preference is largely consistent with the
methylation patterns observed around non-CpG sites, with
NTACACCN and NTACAGCN being the most-favoured
sites for DNMT3A and DNMT3B, respectively. The non-
CpG-specific flanking preferences are identical to non-CpG
motifs reported in tissues where either DNMT3A predom-
inantly contributes to de novomethylation, such as neurons
or oocytes, or in ES cells, where DNMT3B seems to con-
tribute to the majority of non-CpG methylation (2,5,20,55)
– confirming that the methylation patterns observed in
these cells are indeed a footprint of enzyme-specific de novo
DNMT activities.
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Figure 5. Replacement of Arg with Lys in DNMT3A resembles DNMT3B sequence preferences. (A) Bar plots indicating average methylation scores at
CpG sites followed by A, T, C and Gs (CpGpN). Average methylation for CpGpNs falling into one of the four categories was calculated from WGBS
data obtained from Dnmt-TKO ES cells expressing either DNMT3A2 I714N (= residue 492 in mouse DNMT3A2) or R836K (= residue 613 in mouse
DNMT3A2). (B) Nucleotide composition at top 5% from 8-mers ranked by CpGmethylation in DNMT3A2 I714N or R836K -expressing TKO cells. Top
10methylated sequences are shown. (C) Heatmap ofmethylation preferences at all CpG 8-mer sequences shows similarities and differences between samples
analysed in this study. Shown are methylation scores scaled by sample (columns). Unsupervised clustering indicates similarities between samples (columns)
and 8-mers (rows). Legend indicates values scaled per sample. QKO denotes Dnmt-TKO; Setd2-KO cells, r1 and r2 denote independent replicates.
We furthermore show here that genomic sites preferen-
tially bound by DNMT3A or DNMT3B show elevated
methylation at cytosines with preferred nucleotides at the
+2 position. However, through a series of experiments us-
ing different mutant lines, we show that flanking sequence
preference does not stem from the differential localisation
of the de novoDNMTs to the genome, but can be attributed
to minor variations in the structure of the TRD loop in the
catalytic domain. Direct comparison of protein sequences
and structures of DNMT3A (46) or DNMT3B (61) to-
gether with DNA indicates a variant residue that contacts
position +2 downstream of the methylated CpG in the ma-
jor groove of the DNA. The arginine side chain of this
residue in human DNMT3A (R836) contacts purines on
the opposite strand from the methylated CpG, while a ly-
sine in human DNMT3B at the same position (K777) con-
tacts purines on the methylated strand. The latter interac-
tion was recently shown to influence the flanking prefer-
ence of DNMT3B for CpGpG sites in vitro (30,61), sug-
gesting that R836 could play similar roles in determining
DNMT3A preferences for purines on the opposing strand,
resulting in the observed CpGpYflanking preference on the
methylated strand. To shed light on the atomistic details
of the DNMT3A/DNA duplex interactions we performed
MD simulations with decameric DNA products contain-
ing favoured and disfavoured flanking sequences (difference
at position +2). The quantification of interaction distances
along the MD trajectories provides information that goes
beyond interpretations of crystal structures. The favoured
DNA sequence andR836 display two conformational states
‘R836-in’ and ‘R836-out’. In the first state stabilizing hy-
drogen bonds between the side chain of R836 and the G
that base-pairs with the C at position +2 of the favoured
sequence are formed, whereas in the latter only weaker van
derWaals contacts are observed. This dynamic switching of
R836 is fully consistent with recent crystal structures that
describe flexible conformations of the R836 side chain, de-
pending on the flanking sequence (46,62). By introducing
the lysine found in DNMT3B at the corresponding residue
in mouse DNMT3A2 (R836K) we show that the flanking
sequence preference of DNMT3A is almost completely re-
verted to resemble that of DNMT3B. Together with our
molecular dynamics simulations, these results support a
sequence-dependent conformation of the R836 side chain,
and pinpoint R836 as a critical residue in mediating the
flanking sequence preferences observed for DNMT3A. In-
terestingly, this arginine is conserved throughout all genes
annotated as Dnmt3a in jawed vertebrates, teleost species
and in the jawless vertebrate Lamprey (64). The lysine in
DNMT3B on the other hand, is only conserved in jawed
vertebrates, while Arg, Lys or Asparagine can be found at
the same position in other species (64). It will be interesting
to investigate if DNAmethylation is influenced by flanking-
sequence preference in these species, and if this can be ex-
plained by a conserved role of the side chain at this position.
Understanding the sequence-context-dependent methy-
lation activities of DNMT3A and DNMT3B in living
cells provides novel insights into how DNA sequence
could shape DNA methylation patterns. We suggest that
sequence-dependent de novo methylation provides an addi-
tional regulatory layer of the methylome landscape with po-
tential impact on gene activity through recognition of the
methylated cytosine in different sequence contexts. This is
for instance exemplified by MeCP2, a methyl-binding pro-
tein with in vitro and in vivo binding preference for methy-
lated CpApC and to some extent CpApT sites (6). Methy-
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lated CpApC sites drive recruitment of this protein in neu-
ronal cells and lack of DNMT3A has been shown to disrupt
this localization, resulting in changes of gene expression rel-
evant for neuronal function (6,65). In addition, several tran-
scription factors (TFs) have been shown to be influenced
by the presence of DNA methylation in their recognition
motifs (38,66,67). One could speculate that DNMT-specific
flanking sequence preferences together with their differen-
tial genomic binding and cell-type-specific activities could
influence genomic binding of TFs in a context-dependent
manner. Loss and gain of function mutations in the de novo
DNAmethyltransferases and the corresponding changes in
DNA methylation patterns have been associated with nu-
merous diseases and cancers (68,69). Future studies should
help to address how the here-described differences in de novo
methylation activities contribute to the observed TF bind-
ing and gene regulation differences in healthy and diseased
tissues.
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Schübeler,D. (2015) Competition between DNA methylation and
transcription factors determines binding of NRF1. Nature, 528,
575–579.
39. Gaidatzis,D., Lerch,A., Hahne,F. and Stadler,M.B. (2015) QuasR:
quantification and annotation of short reads in R. Bioinformatics, 31,
1130–1132.
40. Martin,M. (2011) Cutadapt removes adapter sequences from
high-throughput sequencing reads. EMBnet.journal, 17, 10–12.
41. Pedersen,B.S., Eyring,K., De,S., Yang,I.V. and Schwartz,D.A. (2014)
Fast and accurate alignment of long bisulfite-seq reads. arXiv doi:
https://arxiv.org/abs/1401.1129, 13 May 2014, preprint: not peer
reviewed.
42. Li,H. (2013) Aligning sequence reads, clone sequences and assembly
contigs with BWA-MEM. arXiv doi: https://arxiv.org/abs/1303.3997,
26 May 2013, preprint: not peer reviewed.
43. Garcı́a-Alcalde,F., Okonechnikov,K., Carbonell,J., Cruz,L.M.,
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